This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
CP Pharmaceuticals Ltd.
CP Pharmaceuticals Ltd., headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and specialty medicines. Founded in the early 2000s, the company has established a strong presence in key operational regions across Europe and beyond. With a diverse portfolio that includes injectable products, oral solid dosage forms, and advanced drug delivery systems, CP Pharmaceuticals is recognised for its commitment to quality and innovation. The company’s unique approach to product development and stringent quality control measures have positioned it as a trusted partner in the healthcare sector. Notable achievements include securing multiple regulatory approvals and expanding its market reach, solidifying CP Pharmaceuticals Ltd. as a leader in the pharmaceutical landscape.
DitchCarbon Score
How does CP Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CP Pharmaceuticals Ltd.'s score of 28 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CP Pharmaceuticals Ltd., headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Wockhardt Limited, and any emissions data would be inherited from this parent organization. As of now, CP Pharmaceuticals Ltd. has not set specific reduction targets or made climate pledges that are publicly documented. The absence of detailed emissions data and reduction initiatives suggests that the company may still be in the early stages of formalising its climate commitments. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. CP Pharmaceuticals Ltd. may benefit from aligning with industry standards and initiatives to enhance its environmental performance in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 1,801,110 |
| Scope 2 | - |
| Scope 3 | 24,596,930 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CP Pharmaceuticals Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
